Davide Capodanno/X
Nov 4, 2025, 09:10
OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X.
“In this post hoc analysis of patients with acute coronary syndromes in the OCCUPI trial, the primary outcome—1-year composite of cardiac death, myocardial infarction, stent thrombosis, or ischemia-driven target vessel revascularisation—occurred in 4.9% of the OCT-guided group versus 9.5% in the angiography-guided group (HR 0.50, 95% CI 0.29–0.87; p=0.011; p=0.273 for interaction). Such benefit was particularly observed in patients who achieved stent optimisation by OCT.”
Read ARTICLE here EDITORIAL here.
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India
-
Oct 10, 2026, 09:52Yuria Ito: Should Ferritin Testing Become a Routine Part of Prenatal Care in Japan?
-
Oct 10, 2026, 09:48Ahmed Alotaibi: Can We “Remove” the ABO Problem from Group O Platelets?
-
Oct 10, 2026, 09:31Help Shape the New ASH Iron Deficiency Guidelines – American Society of Hematology
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness